Filter Results
:
(43)
Show Results For
-
All HBS Web
(206)
- Faculty Publications (43)
Show Results For
-
All HBS Web
(206)
- Faculty Publications (43)
Page 1 of
43
Results
→
- September 2021
- Article
Joint Problem-solving Orientation in Fluid Cross-boundary Teams
By: Michaela J. Kerrissey, Anna T. Mayo and Amy C. Edmondson
Using interviews, a national field survey, and an online laboratory study, we have examined teamwork in fluid cross-boundary teams. Across three studies, we qualitatively discovered and quantitatively explored "joint problem-solving orientation" as a new team factor....
View Details
Keywords:
Problem Solving;
Cross-boundary Teams;
Groups and Teams;
Problems and Challenges;
Performance
Kerrissey, Michaela J., Anna T. Mayo, and Amy C. Edmondson. "Joint Problem-solving Orientation in Fluid Cross-boundary Teams." Academy of Management Discoveries 7, no. 3 (September 2021): 381–405.
- January 2021 (Revised March 2022)
- Case
Into the Raging Sea: Final Voyage of the SS El Faro
By: Joseph B. Fuller and Mel Martin
Captain Michael Davidson of the container ship SS El Faro was determined to make his planned shipping trip on time—but a hurricane was approaching his intended path. To succeed, Davidson and his fellow officers must plot a course to avoid the storm in the face of...
View Details
Keywords:
Power Dynamics;
Management;
Leadership Style;
Crisis Management;
Failure;
Groups and Teams;
Rank and Position;
Decision Choices and Conditions;
Shipping Industry;
United States
Fuller, Joseph B., and Mel Martin. "Into the Raging Sea: Final Voyage of the SS El Faro." Harvard Business School Case 321-014, January 2021. (Revised March 2022.)
- Article
Healthy Buildings in 2070
By: John D. Macomber and Joseph G. Allen
Fifty years seems a very long time in the future for most industries. Not so in buildings and real estate; built structures routinely last decades if not hundreds of years, as long as they are economically competitive. Any discussion of the 50-year future has to...
View Details
Keywords:
Health & Wellness;
Real Estate;
Architectural Innovation;
Public Health;
Health;
Buildings and Facilities;
Well-being
Macomber, John D., and Joseph G. Allen. "Healthy Buildings in 2070." The Bridge 50, no. S (Winter 2020): 11–14. (Special 50th Anniversary Issue edited by Ronald M. Latanision.)
- September 2020
- Teaching Note
TransDigm in 2017: The Beginning of the End or the End of the Beginning?
By: Benjamin C. Esty and Daniel Fisher
Teaching Note for HBS Case No. 720-422. TransDigm was a highly acquisitive company that manufactured a wide range of highly engineered aerospace parts for both military and commercial customers. Over the ten years ending in 2016, its stock price had increase ten times,...
View Details
Keywords:
Value Capturing;
Pricing Strategy;
Supplier Power;
Buyer Power;
Porter's Five Forces;
Bargaining Power;
Monopoly;
Aerospace;
Acquisition Strategy;
Value Drivers;
Ethical Behavior;
Regulation;
Growth Strategy;
Business Ethics;
Defense;
Procurement;
Sustainability;
Value-Based Business Strategy;
Acquisition;
Ethics;
Private Equity;
Financial Strategy;
Growth Management;
Performance Evaluation;
Business Strategy;
Competitive Strategy;
Horizontal Integration;
Value Creation;
Competitive Advantage;
Aerospace Industry;
Air Transportation Industry;
United States
- September 2020
- Case
Lojas Americanas: Project DNA and the 'People Machine'
By: Boris Groysberg, Eric Lin and Sarah L. Abbott
Lojas Americanas (“Americanas”) was one of the largest retailers in Brazil. Via its stores, digital platform and Innovation Engine, the company served more than 38 million people. In recent years, Americanas had enjoyed rapid growth; growing from 98 stores in 2001 to...
View Details
Keywords:
Retail;
Data Analytics;
Growth And Development;
Analytics and Data Science;
Analysis;
Training;
Performance;
Employees;
Management;
Human Resources;
Leadership Development;
Retail Industry;
Brazil
Groysberg, Boris, Eric Lin, and Sarah L. Abbott. "Lojas Americanas: Project DNA and the 'People Machine'." Harvard Business School Case 421-038, September 2020.
- June 2020
- Case
Breakthroughs at Blueprint Medicines
By: Richard G. Hamermesh, Kathy Giusti and Susie L. Ma
Precision medicine company Blueprint Medicines was building a successful track record for bringing drug therapies to market 40% faster than average. The company had spent $40 million dollars and two years building a compound library that became its drug development...
View Details
Keywords:
Precision Medicine;
Cancer;
Biotechnology;
Drug Development;
Strategy;
Expansion;
Science;
Genetics;
Information Technology;
Entrepreneurship;
Organizational Culture;
Management;
Growth and Development;
Pharmaceutical Industry;
United States;
Cambridge;
Massachusetts
Hamermesh, Richard G., Kathy Giusti, and Susie L. Ma. "Breakthroughs at Blueprint Medicines." Harvard Business School Case 820-001, June 2020.
- April 2020 (Revised July 2020)
- Supplement
TransDigm in 2017: The Beginning of the End or the End of the Beginning?
By: Benjamin C. Esty and Daniel Fisher
TransDigm was a highly acquisitive company that manufactured a wide range of highly engineered aerospace parts for both military and commercial customers. Over the ten years ending in 2016, its stock price had increase ten times, and both EBITDA and revenues had grown...
View Details
- April 2020 (Revised July 2020)
- Case
TransDigm in 2017: The Beginning of the End or the End of the Beginning?
By: Benjamin C. Esty and Daniel Fisher
TransDigm was a highly acquisitive company that manufactured a wide range of highly engineered aerospace parts for both military and commercial customers. Over the ten years ending in 2016, its stock price had increased ten times, and both EBITDA and revenues had grown...
View Details
Keywords:
Value Capturing;
Pricing Strategy;
Supplier Power;
Buyer Power;
Porter's Five Forces;
Bargaining Power;
Monopoly;
Aerospace;
Acquisition Strategy;
Value Drivers;
Ethical Behavior;
Regulation;
Growth Strategy;
Business Ethics;
Defense;
Procurement;
Sustainability;
Value-Based Business Strategy;
Acquisition;
Ethics;
Private Equity;
Financial Strategy;
Growth Management;
Performance Evaluation;
Business Strategy;
Competitive Strategy;
Horizontal Integration;
Value Creation;
Competitive Advantage;
Aerospace Industry;
Air Transportation Industry;
United States
Esty, Benjamin C., and Daniel Fisher. "TransDigm in 2017: The Beginning of the End or the End of the Beginning?" Harvard Business School Case 720-422, April 2020. (Revised July 2020.)
- Article
The Role of Interactivity in Local Differential Privacy
By: Matthew Joseph, Jieming Mao, Seth Neel and Aaron Leon Roth
We study the power of interactivity in local differential privacy. First, we focus on the difference between fully interactive and sequentially interactive protocols. Sequentially interactive protocols may query users adaptively in sequence, but they cannot return to...
View Details
Joseph, Matthew, Jieming Mao, Seth Neel, and Aaron Leon Roth. "The Role of Interactivity in Local Differential Privacy." Proceedings of the IEEE Annual Symposium on Foundations of Computer Science (FOCS) 60th (2019).
- October 2019
- Supplement
Granite Equity Compounding Returns Calculations
By: Victoria Ivashina and Terrence Shu
- June 2019
- Article
Brokers vs. Retail Investors: Conflicting Interests and Dominated Products
By: Mark Egan
I study how brokers distort household investment decisions. Using a novel convertible bond dataset, I find that consumers often purchase dominated bonds—cheap and expensive versions of otherwise identical bonds coexist in the market. The empirical evidence suggests...
View Details
Keywords:
Brokers;
Fiduciary Standard;
Consumer Finance;
Structured Products;
Household;
Investment;
Decisions;
Motivation and Incentives;
Conflict of Interests
Egan, Mark. "Brokers vs. Retail Investors: Conflicting Interests and Dominated Products." Journal of Finance 74, no. 3 (June 2019): 1217–1260.
- February 2019
- Teaching Note
Talent@Tencent
By: Tarun Khanna
Late in 2016, two senior human resources (HR) executives at Tencent Holdings (Tencent), China’s leading Internet services firm, are assessing the effectiveness of the company’s talent management practices in responding to Tencent’s sustained hypergrowth. Over the...
View Details
- Spring 2018
- Article
The Enemy of My Enemy: The Soviet Union, East Germany, and the Iranian Tudeh Party's Support for Ayatollah Khomeini
By: Jeremy Friedman
This article examines the strategy of the Iranian Tudeh Party in concert with its Soviet and East German patrons and allies during and after the Iranian revolution of 1979. The article assesses the thinking behind the Tudeh’s strategy of unwavering support for...
View Details
Friedman, Jeremy. "The Enemy of My Enemy: The Soviet Union, East Germany, and the Iranian Tudeh Party's Support for Ayatollah Khomeini." Journal of Cold War Studies 20, no. 2 (Spring 2018): 3–37.
- May 2017
- Teaching Note
Partners Group: Ain't No Mountain High Enough
Partners Group (PG), a Swiss-based PE manager, initiated a series of strategic shifts and evolved from a predominately fund-of-funds manager into a large, multi-asset class PE firm focused on direct investments. PG was the first PE firm to go public in 2006. A number...
View Details
- April 2017
- Case
Imprimis (A)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case examines the strategic choices and evolving business model of Imprimis Pharmaceuticals from the perspective of CEO Mark Baum. The (A) case provides a brief history of the company and of the compounding business, outlining the challenges faced by Imprimis in...
View Details
Keywords:
Strategy;
Healthcare;
Drug Compounding;
Pharmaceuticals;
Compounding;
Drug Development;
Decision-making;
Mark Baum;
Imprimis;
Small Business;
Decisions;
Cost vs Benefits;
Business Strategy;
Business Model;
Decision Choices and Conditions;
Pharmaceutical Industry;
United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (A)." Harvard Business School Case 717-426, April 2017.
- April 2017
- Supplement
Imprimis (B)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A). It describes the company’s decision to enter into the pharmaceutical compounding business in 2013–2014. Imprimis purchased a compounded ophthalmological medication called Dropless Therapy, which was injected into patients’...
View Details
Keywords:
Healthcare;
Drug Compounding;
Drug Development;
Pharmaceuticals;
Small Business;
Decision-making, Business Model;
Mark Baum;
Imprimis;
Decision Making;
Strategy;
Health Care and Treatment;
Policy;
Pharmaceutical Industry;
United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (B)." Harvard Business School Supplement 717-496, April 2017.
- April 2017
- Supplement
Imprimis (C)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the...
View Details
Keywords:
Health Care and Treatment;
Cost;
Moral Sensibility;
Competitive Strategy;
Decision Choices and Conditions;
Pharmaceutical Industry;
United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (C)." Harvard Business School Supplement 717-497, April 2017.
- April 2017
- Supplement
Imprimis (D)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A, B, & C). It describes Imprimis’s 2015 decision to develop a $1 per pill compounded alternative to Daraprim, the branded drug that had recently undergone an extreme price hike, raising its price to $750 per pill. Imprimis also...
View Details
Keywords:
Decision Choices and Conditions;
Growth and Development Strategy;
Pharmaceutical Industry;
United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (D)." Harvard Business School Supplement 717-498, April 2017.
- September 2016
- Case
Partners Group: Ain't No Mountain High Enough
By: Nori Gerardo Lietz and Ricardo Andrade
Partners Group (PG), a Swiss-based PE manager, initiated a series of strategic shifts and evolved from a predominately fund-of-funds manager into a large, multi-asset class PE firm focused on direct investments. PG was the first PE firm to go public in 2006. A number...
View Details
Lietz, Nori Gerardo, and Ricardo Andrade. "Partners Group: Ain't No Mountain High Enough." Harvard Business School Case 217-035, September 2016.
- July–August 2015
- Article
The Secret of Singapore: Why Cuba Should Look to Lee Kuan Yew's Thriving City-State for Economic Inspiration
By: Debora L. Spar
Between 1965 and 1991, Singapore grew at an astonishing compound annual growth rate of nearly 14%. Critics of the island's performance accused its celebrated leader, Lee Kuan Yew, of thinly veiled tendencies toward communism and authoritarianism; they argued that the...
View Details
Keywords:
Economic Models;
Communism;
Economic Policy;
Economic Reform;
Angel Investors;
Authoritarianism;
Economic Systems;
Economy;
Policy;
Government and Politics;
Singapore;
Cuba
Spar, Debora L. "The Secret of Singapore: Why Cuba Should Look to Lee Kuan Yew's Thriving City-State for Economic Inspiration." Foreign Policy 213 (July–August 2015).